All PlansBilling CodesHigh impact
New Claims Editing Rules To Be Implemented in December 2026
BCBS New Mexico·NM · Ophthalmology, Endocrinology, Rheumatology·Reimbursement
Effective date
Dec 1, 2026
We identified it
Aug 22, 2026
Summary
Effective December 1, 2026, Blue Cross Blue Shield of New Mexico will implement new claims editing rules in the Lyric software database that add maximum unit limits and frequency restrictions for five specific drug codes (J0897, J0178, J2778, J2502, Q5128) and enforce proper application of drug wastage modifiers (JW/JZ) on single-use vial claims. Claims that fail these edits will receive denial reason codes beginning with the letter 'G'.
Action Required
By November 15, 2026: Billing team must update all claim submission processes and billing software edits to enforce the new unit limits and frequency restrictions: J0897 (max 60 units per 6 months for osteoporosis), J0178 (max 4 units per 4 weeks), J2778 (max 5 units per 4 weeks), J2502 (max 60 units per 4 weeks for acromegaly), and Q5128 (max 10 units per 4 weeks for wet AMD/RVO/mCNV). Additionally, audit all drug claims for single-use vials to ensure JW or JZ modifiers are properly applied; implement system validations to flag missing or incorrectly applied wastage modifiers before claim submission. Train providers and coders on the new frequency and diagnosis-specific restrictions to prevent claim denials. Use Clear Claim Connection tool to test coding combinations prior to December 1, 2026. Failure to comply will result in claims being denied with 'G' reason codes and delayed reimbursement.